Skip to content
Business · World
Eli Lilly to acquire Merida Biosciences for $2.88 billion to expand autoimmune treatments
1 sourceFirst reported 2 hours agoUpdated 2 hours ago
AI summary: catch up in 20 seconds
Summarising the coverage…
Generated by AI from the 1 sources below · always verify with the originals
All coverage (1)
In this storyPharmaceuticals
Comments · 0 (subscribers)
Sign in to join the discussion.
No comments yet. Be the first to join the discussion.